Japanese Pharma Biz Loses Kidney Transplant Therapy Patent
An Australian biotech company has persuaded a European appeals panel to revoke the patent of Japanese rival Takeda over a treatment for kidney transplant patients, proving it is doubtful whether the...To view the full article, register now.
Already a subscriber? Click here to view full article